Pharmaceuticals, Biotechnology and Life Sciences
Hikma Pharmaceuticals and a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd. (Sun Pharma), the world’s fourth largest specialty generic pharmaceutical company, announced today that they have entered into an exclusive licensing and distribution agreement for Ilumya, an innovative biologic product, for the Middle East and North Africa (MENA) region.
Vyripharm Biopharmaceuticals and Regis Technologies, Inc. Have Signed Off on a Master Drug Program Agreement for Expediting cGMP Manufacture of Our Antiviral Agents for Diagnostic Evaluation of COVID-19.
LONDON–(BUSINESS WIRE)–#Analytics–One of the world’s leading analytics solutions provider, Quantzig, announces the completion of its recent article that presents comprehensive…
Amabiotics unveils rebranding, new advisors and the appointment of Dr. Nicole McKnight to CEO NEW YORK–(BUSINESS WIRE)–Amabiotics Inc., a global…
Steele, former president/chief executive officer of Geisinger Health System, will lead the center’s board of directors DUARTE, Calif.–(BUSINESS WIRE)–#CityofHope–Preeminent health…
Global capsule and equipment developer and manufacturer, Lonza has introduced an enhanced product line aimed at tackling concerns around bias during blinded clinical trials.
DUBLIN–(BUSINESS WIRE)–The “Transdermal Skin Patches Market Global Report 2020-30” report has been added to ResearchAndMarkets.com’s offering. The global transdermal skin…
Javier Starkand and Sean Breen Promoted to Partner NEW YORK–(BUSINESS WIRE)–Consonance Capital Partners (CCP), a leading U.S. healthcare focused private…
PERTH, Australia & CHARLOTTE, N.C.–(BUSINESS WIRE)–Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global named…
DUBLIN–(BUSINESS WIRE)–The “Stem Cell Therapy Market to 2027 – Global Analysis and Forecasts by Type; Treatment; Application; End User, and…